Search Instructions:

* Filter the ENTIRE resource library: Choose a Subject OR a Type of Item at the bottom of the page from the buttons to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.

Browse Items (195 total)

  • Subject is exactly "Treatment & Care"

casirivimab and imdevimab EUA fact sheet for healthcare providers_0.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-21
Description: Casirivimab and imdevimab to be administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct…

default_website_icon.png
Creator: Infectious Diseases Society of America (IDSA)
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-22
Description: These are regularly updated guidelines on the treatment and management of patients with COVID-19.

default_publication_icon.png
Creator: Manzano, Giovanna S., Jared K. Woods, and Anthony A. Amato.
Subject: Treatment & Care
Item Type: Publication
Date Last Updated: 2020-11-20
Description: The syndrome of Covid-19 infection includes myalgias and elevated creatine kinase levels in at least a third of patients. Whether the elevation in creatine kinase level is caused by viral infection of muscle, toxic effects of cytokines, or another…

Monoclonal Antibody Therapeutics Final.pdf
Creator: NETEC
Subject: Treatment & Care
Item Type: Webinar
Date Last Updated: 2020-11-25
Description: In this webinar, we will identify important considerations involving Monoclonal Antibody Therapeutics available for emergency use authorization (EUAs) for mild-to-moderate COVID-19 cases, discuss recent criteria for the FDA approved investigational…

Fact Sheet for Healthcare Providers EUA for baricitinib.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-11-19
Description: EUA: For emergency use by healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or…

EUA-Fresenius-CRRT-HCP.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-04-30
Description: EUA: To provide continuous renal replacement therapy (CRRT) to treat patients in an acute care environment during the COVID-19 pandemic.

Fact Sheet Health Care Providers 10..22.20.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-01
Description: EUA: For emergency use by licensed healthcare providers for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age…

HCP Fact Sheet.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-05-08
Description: EUA: To maintain sedation via continuous infusion in patients older than age 16 with suspected or confirmed COVID-19 who require mechanical ventilation in an ICU setting 2

Attachment 1 Healthcare Provider Fact Sheet (clean 08132020).pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-13
Description: EUA: To be used as a replacement solution only in adult patients treated with continuous renal replacement therapy (CRRT), and for whom regional citrate anticoagulation is appropriate, in a critical care settingFor continuous renal replacement…

Convalescent Plasma EUA FS HCP FINAL.web_.08232020_11.00.pdf
Creator: U.S. Food and Drug Administration
Subject: Treatment & Care
Item Type: Guide
Date Last Updated: 2020-08-23
Description: Fact sheet for Convalescent PlasmaEUA: For the treatment of hospitalized patients with Coronavirus Disease 2019 (COVID-19)